Michael Lee, MD, Chief of Cardiology

Dr. Lee has more than 25 years of medical experience, primarily in Los Angeles, California region. He recently served as Director of Cardiology at Mission Community Hospital and as Medical Director at Carelon Health. He will also serve as Chief of Cardiology for Griffin Hospital.

Dr. Lee holds a bachelor’s degree in biology from the University of California, San Diego and a medical degree from St. George University School of Medicine in Grenada. He completed a fellowship in cardiology at St. Luke’s-Roosevelt Hospital Center College of Physicians and Surgeons at Columbia University and a fellowship in interventional cardiology at Cedars-Sinai Medical Center at the UCLA School of Medicine. He is board-certified in Internal Medicine, Clinical Cardiology and Interventional Cardiology.

Dr. Lee has a strong background in clinical instruction, including serving as Clinical Instructor and Associate Director for Interventional Cardiology Research at the UCLA School of Medicine. He has been an editor and reviewer for several medical journals, including Journal of the American College of Cardiology, Lancet, and the Journal of Interventional Cardiology. He has published more than 120 research papers and has been a frequent presenter at medical conferences, symposiums and colleges for more than a decade.

Recent Publications:

Cardiovascular Revascularization Medicine:

Percutaneous coronary intervention with an initial bolus of low-dose heparin in biomarker negative patients. Cardiovasc Revasc Med 2020

Clinical and Experimental Pharmacology and Physiology:

A Relationship between Unrecognized Anaemia and the Development of Type 2 Diabetes Mellitus in Patient with Cardiovascular Risks.  2021

Cardiovascular Revascularization Medicine:

Percutaneous Treatment of Unprotected Left Main Disease with Thin Strut Durable Polymer or Early-Generation Thicker Strutted and Coated Bioabsorbable Polymer Drug-eluting Stents in a Large-Scale Registry. 2021.

Cardiovascular Revascularization Medicine:

Diagnostic Yield of Coronary Angiography in Asymptomatic Orthotopic Liver Transplantation Candidates. 2021.

Public Library of Science (PLOS) One:

Long-term Outcomes of Peripheral Arterial Disease Patients with Significant Coronary Artery Disease undergoing Percutaneous Coronary Intervention. 2021